Photo
Language
English
Title and Department
Research Associate Professor
Department of Medicine, Division of Allergy, Pulmonary and Critical CAre Medicine
Professional bio
Weisong Zhou, PhD, is a Research Associate Professor of Medicine in the Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, at Vanderbilt University Medical Center.
Dr. Zhou received his bachelor’s degree from Yangzhou University, China, and his PhD degree from the University of Kentucky. He was recruited to Vanderbilt University Medical Center as a Postdoctoral Fellow in 2001. He was promoted to Research Fellow, Research Assistant Professor, and Research Associate Professor of Medicine during his years working at Vanderbilt University.
Dr. Zhou’s research program focuses on the role of prostaglandins in inflammation and immune responses in allergic lung diseases. The major theme of his research program is to understand the mechanisms by which prostacyclin regulates the proliferation and function of CD4 T cells and type 2 innate lymphoid cells (ILC2) in allergy. He received K99 funding from NIH in 2009 and has played a pivotal role in the airway allergy programs at the Center for Lung Research.
Dr. Zhou has authored or co-authored 42 papers from the research conducted at Vanderbilt University, and some of these papers were published in high-impact journals, such as PNAS and the Journal of Immunology. He has also been invited to review manuscripts for peer-reviewed journals.
Dr. Zhou received his bachelor’s degree from Yangzhou University, China, and his PhD degree from the University of Kentucky. He was recruited to Vanderbilt University Medical Center as a Postdoctoral Fellow in 2001. He was promoted to Research Fellow, Research Assistant Professor, and Research Associate Professor of Medicine during his years working at Vanderbilt University.
Dr. Zhou’s research program focuses on the role of prostaglandins in inflammation and immune responses in allergic lung diseases. The major theme of his research program is to understand the mechanisms by which prostacyclin regulates the proliferation and function of CD4 T cells and type 2 innate lymphoid cells (ILC2) in allergy. He received K99 funding from NIH in 2009 and has played a pivotal role in the airway allergy programs at the Center for Lung Research.
Dr. Zhou has authored or co-authored 42 papers from the research conducted at Vanderbilt University, and some of these papers were published in high-impact journals, such as PNAS and the Journal of Immunology. He has also been invited to review manuscripts for peer-reviewed journals.